NIH-funded research NIH-funded research

ARTFL LEFFTDS Frontotemporal Dementia study cycle 2

Official title: ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration, Cycle 2 (ALLFTD2)

Funded at Mayo Clinic Rochester · NIH-11595432 · Data updated 2026-11-12

This NIH grant supports a longitudinal study to understand and track frontotemporal lobar degeneration (FTLD) and related disorders in people, aiming to uncover biomarkers and disease progression information that could help patients and families.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionMayo Clinic Rochester
NIH-funded
Lab location1 site (Rochester, United States)
Project startSeptember 15, 2019
Project endAugust 31, 2030
Funding year2026
Award (this year)$540
NIH project number3U19AG063911-07S4
Project IDNIH-11595432 on NIH RePORTER

Who could benefit from this research

Could help

Individuals with or at risk for frontotemporal lobar degeneration, including familial forms, who are willing to participate in long-term follow-up.

Less likely to help

Some participants may not experience direct personal benefit, as research aims to improve knowledge and future treatments rather than immediate care for each person.

What this research studies

This project follows people with FTLD, including inherited forms, over time to map how the disease starts and progresses. It looks at proteins linked to FTLD and how they relate to symptoms and brain changes, with the goal of identifying markers that predict outcomes. Researchers also build on prior ARTFL/LEFFTDS work to refine approaches for diagnosis and monitoring and to explore how new therapies might work. Participation would involve regular assessments, imaging, and biomarker studies over multiple years so patients and their families could contribute to advances in care.

Why it matters

Potential benefit: If successful, findings could lead to earlier diagnosis, better monitoring, and new targets for therapies to slow or treat FTLD in patients.

How similar studies have gone: Previous ARTFL/LEFFTDS work has established a strong framework and meaningful insights, guiding ongoing progress in FTLD research.

Where this research is happening

  • Mayo Clinic Rochester
    Rochester, United States
    Active

Researchers

  • Principal investigator: Boeve, Bradley F — Mayo Clinic Rochester
  • Study coordinator: Boeve, Bradley F

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.